Folgen
Hima Anbunathan
Titel
Zitiert von
Zitiert von
Jahr
c-Jun overexpression in CAR T cells induces exhaustion resistance
RC Lynn, EW Weber, E Sotillo, D Gennert, P Xu, Z Good, H Anbunathan, ...
Nature 576 (7786), 293-300, 2019
5672019
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
JW Harbour, EDO Roberson, H Anbunathan, MD Onken, LA Worley, ...
Nature Genetics, 2013
5322013
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
EW Weber, KR Parker, E Sotillo, RC Lynn, H Anbunathan, J Lattin, ...
Science 372 (6537), 2021
365*2021
Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes
CL Decatur, E Ong, N Garg, H Anbunathan, AM Bowcock, MG Field, ...
JAMA ophthalmology 134 (7), 728-733, 2016
2462016
Punctuated evolution of canonical genomic aberrations in uveal melanoma
MG Field, MA Durante, H Anbunathan, LZ Cai, CL Decatur, AM Bowcock, ...
Nature communications 9 (1), 116, 2018
1652018
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
S Heitzeneder, KR Bosse, Z Zhu, D Zhelev, RG Majzner, MT Radosevich, ...
Cancer Cell 40 (1), 53-69. e9, 2022
892022
Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer
C Diquigiovanni, C Bergamini, C Evangelisti, F Isidori, A Vettori, N Tiso, ...
International journal of cancer 143 (7), 1706-1719, 2018
462018
CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts
M Ammar, CT Jordan, L Cao, E Lim, C Bouchlaka Souissi, A Jrad, ...
British Journal of Dermatology 174 (2), 330-337, 2016
402016
Integrated genomics point to immune vulnerabilities in pleural mesothelioma
A Nastase, A Mandal, SK Lu, H Anbunathan, D Morris-Rosendahl, ...
Scientific Reports 11 (1), 19138, 2021
24*2021
Genome‐wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families
M Ammar, C Bouchlaka‐Souissi, CA Helms, I Zaraa, CT Jordan, ...
British Journal of Dermatology, 2013
232013
Integrative copy number analysis of uveal melanoma reveals novel candidate genes involved in tumorigenesis including a tumor suppressor role for PHF10/BAF45a
H Anbunathan, R Verstraten, AD Singh, JW Harbour, AM Bowcock
Clinical Cancer Research, clincanres. 3052.2018, 2019
202019
The Molecular Revolution in Cutaneous Biology: The Era of Genome-Wide Association Studies and Statistical, Big Data, and Computational Topics
H Anbunathan, AM Bowcock
Journal of Investigative Dermatology 137 (5), e113–e118, 2017
202017
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
S Kaczanowska, T Murty, A Alimadadi, CF Contreras, C Duault, ...
Cancer Cell 42 (1), 35-51. e8, 2024
42024
Validation of a Specific Missense GTF2I Mutation in More Indolent Thymic Epithelial Tumours
S Gennatas, H Anbunathan, A Montero, AG Nicholson, S Popat, ...
JOURNAL OF THORACIC ONCOLOGY 10 (9), S403-S403, 2015
22015
Molecular landscape of malignant mesothelioma from whole exome sequencing
SK Lu, H Anbunathan, S Popat, MER O'Brien, E Lim, AM Fernandez, ...
JOURNAL OF THORACIC ONCOLOGY 10 (9), S253-S253, 2015
12015
A novel, high-throughput full-length scRNA-seq workflow for improved biomarker discovery
P Xu, J Liu, Y Ryan, K Tori, X Li, H Anbunathan, M Covington, T Uchiyama, ...
Cancer Research 84 (6_Supplement), 316-316, 2024
2024
Demystifying tumor heterogeneity with a fully automated, high-throughput single-cell DNA-Seq (scDNA-seq) workflow
X Li, R Mendoza, S Leong, H Anbunathan, M Covington, M Fallahi, B Bell, ...
Cancer Research 84 (6_Supplement), 318-318, 2024
2024
Utilizing response in immune checkpoint inhibitor treated cohorts improves clinical applicability of neoantigen immunogenicity predictions
H Anbunathan, N Ravi, RM Pyke, S Dea, RO Chen, SM Boyle
Cancer Research 83 (7_Supplement), 5472-5472, 2023
2023
51 A combination of antigen presentation and T-cell recognition features improves neoantigen immunogenicity predictions
N Ravi, H Anbunathan, RM Pyke, S Dea, P Tandon, RO Chen, SM Boyle
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
2022
119 Sensitive prediction of immunotherapy response by integrating immune infiltration and neoantigen presentation score in late-stage melanoma
B Li, C Abbott, L McDaniel, R Pyke, F Navarro, H Anbunathan, M Synder, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
2022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20